Latest Rosuvastatin Stories
Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina. (PRWEB) March 25,
New Published Study Reveals BergaMet(TM) Added to Statins Enhances Lipid Lowering and Artery Health DENVER, Feb.
Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan.
Baron and Budd reports on study alleging that Lipitor use may cause a significantly increased risk of type 2 diabetes compared to other drugs in its class LOS
An inexpensive and commonly used cholesterol medication could be used to prevent cataracts and reduce a person’s risk of developing dementia, according to research presented over the weekend at the European Society of Cardiology (ESC) Congress in Amsterdam.
Dr Nakano said: "Many randomized clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
Lipitor, one of the most common and popular drugs in the world, is increasingly being linked to the development of diabetes in women.